Status not kept up to date
Lidocaine Combined With Sufentanil for Preventing Catheter-related Bladder Discomfort
NCT05957653 · RenJi Hospital · Updated 24 July 2023
- What is being tested
- lidocaine and sufentanil; Saline
- For
- Prostate Cancer
- Kind of study
- Tests a treatment or device on volunteers. Phase 4.
- Who can join
- Ages 18 years to 79 years. About 140 people. The full rules are on the registry page.
- Where
- Not stated
- When
- Starts or started 7 Oct 2023, ends 30 Oct 2025. Registered 24 July 2023.
- Results
- None posted yet.
In the researchers' words
The goal of this clinical trial is to evaluate the incidence and severity of postoperative catheter-related bladder discomfort after robot-assisted radical prostatectomy. The main question it aims to answer is to evaluate incidence of CRBD immediately after extubation in resuscitation. A total of 20ml of 2% lidocaine and 1μg/ml sufentanil or 20ml normal saline was injected into the bladder of the participants through the catheter. After drug injection, the catheter was clamped for 20 minutes, and then 100ml normal saline was injected into the bladder through the catheter to flush out. Then, the incidence of CRBD was compared between the two groups.